AbbVie (ABBV) Gross Profit (2012 - 2026)

AbbVie (ABBV) has 15 years of Gross Profit data on file, last reported at $10.8 billion in Q1 2026.

• Gross Profit for Q1 2026 came in at $10.8 billion, up 15.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.4 billion (up 9.48% YoY), and the FY2025 annual result was $43.0 billion, up 8.94% from the prior year.
• Gross Profit slipped to $10.8 billion in Q1 2026 per ABBV's latest filing, from $12.1 billion in the prior quarter.
• Over five years, Gross Profit peaked at $12.1 billion in Q4 2025 and troughed at $7.4 billion in Q3 2023.
• A 5-year average of $9.9 billion and a median of $10.2 billion in 2024 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2023 and 2024: Gross Profit dropped 23.98% in 2023, then soared 37.7% in 2024.
• A 5-year view of Gross Profit shows it stood at $11.0 billion in 2022, then declined by 21.5% to $8.6 billion in 2023, then grew by 24.53% to $10.7 billion in 2024, then gained by 12.7% to $12.1 billion in 2025, then dropped by 10.62% to $10.8 billion in 2026.
• Business Quant data shows ABBV's Gross Profit at $10.8 billion in Q1 2026, $12.1 billion in Q4 2025, and $10.5 billion in Q3 2025.